Report : Asia Pacific Radiation Dose Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Service/Software (Radiation Dose Management Services and Radiation Dose Management Software), By Medium (Computed Tomography, Radiation and Mammography, Fluoroscopy and Mammography, and Other Medium), and End User (Hospitals, Research and Medical Institutes, and Others)
The hospitals segment by end user is estimated to lead the market growth during the forecast period.
According to a new market research study of “Asia Pacific Radiation Dose Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Service/Software, Medium, End User and Country.”. The Asia Pacific radiation dose management market is expected to reach US$ 82.09 million in 2028 from US$ 35.57 million in 2021. It is estimated to grow at a CAGR of 12.7% from 2021 to 2028. The report highlights trends prevailing in the Asia Pacific radiation dose management market and the factors driving market along with those that act as hindrances.
Rapid advances in medical technology, device manufacturing, and imaging equipment have resulted in the refinement of original procedures with better techniques and an expansion of the indications for procedures. New techniques have been developed, and some techniques are migrated to other imaging modalities. More interventional radiological and nuclear medicine procedures are performed worldwide with high imaging efficiency. These procedures use high doses of radiation, and a longer duration may increase the risk of cancer in patients undergoing these procedures.
As reported by the World Nuclear Association, more than 10,000 hospitals worldwide use radioisotopes in medicine, and 90% of radioisotope procedures are diagnostic.
Market players, such as Bayer Healthcare and Sectra Medical Systems, offer dose management software specifically for RDM in interventional imaging and nuclear medicine. Although CT applications account for a larger share of the radiation dose management market, interventional radiology and nuclear medicine applications are expected to provide significant growth opportunities in the near future.
The Asia Pacific radiation dose management market, by service or software, is segmented into radiation dose management services and radiation dose management software. The Asia Pacific radiation dose management market, by medium, is segmented into computed tomography, radiation, and mammography, fluroscopy and mammography, and other medium. Based on end user, the Asia Pacific radiation dose management market is segmented hospitals, research and medical institutes, others. Geographically, the Asia Pacific radiation dose management market can be divided into China, Japan, India, South Korea, Australia and Rest of Asia Pacific.
FUJIFILM Holdings Corporation, Bayer AG, Bracco Imaging S.p.A, GE Healthcare, Koninklijke Philips N.V., Medsquare, Novarad Corporation, Sectra AB and PACSHealth, LLC are among the leading companies operating in the Asia Pacific radiation dose management market.
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org